NASDAQ : AGRX

Agile Therapeutics, Inc. — Earnings Estimates

$1.51 USD

$0.05 (3.42%)

Volume
119.29K
Average Volume
154.55K
Market Capitalization
$10.43M
P/E Ratio
-0.23
Dividend Yield
0.00%
Price Target
$1.00
Year High
$2.63
Year Low
$0.20
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.46

Annual earnings financials

AGRX financial data with annual/quarterly toggle

AGRX GAAP EPS - Annual & Quarterly

AGRX Sales Revenue - Annual & Quarterly

AGRX Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

AGRX Estimated and Actual Revenue by Quarter
AGRX Estimated and Actual EPS by Quarter
AGRX Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2025-12-30 1 -10.6M -10.6M -10.6M -10.63M -10.63M -10.63M
2025-09-30 1 -10.21M -10.21M -10.21M -10.24M -10.24M -10.24M
2025-06-30 1 -9.42M -9.42M -9.42M -9.45M -9.45M -9.45M
2025-03-30 1 -9.03M -9.03M -9.03M -9.06M -9.06M -9.06M
2024-12-30 1 -6.73M -6.73M -6.73M -6.75M -6.75M -6.75M
2024-09-30 1 -5.61M -5.61M -5.61M -5.63M -5.63M -5.63M
AGRX Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2025-12-30 1 - - - 243.09M 243.09M 243.09M
2025-09-30 1 - - - 234.09M 234.09M 234.09M
2025-06-30 1 - - - 216.08M 216.08M 216.08M
2025-03-30 1 - - - 207.08M 207.08M 207.08M
2024-12-30 1 685.62K 685.62K 685.62K 154.41M 154.41M 154.41M
2024-09-30 1 -274.25K -274.25K -274.25K 128.68M 128.68M 128.68M
AGRX Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2025-12-30 1 17.72M 17.72M 17.72M 0 0 0 0
2025-09-30 1 17.06M 17.06M 17.06M 0 0 0 0
2025-06-30 1 15.75M 15.75M 15.75M 0 0 0 0
2025-03-30 1 15.1M 15.1M 15.1M 0 0 0 0
2024-12-30 1 11.26M 11.26M 11.26M 1 0.1 0.1 0.1
2024-09-30 1 9.38M 9.38M 9.38M 1 -0.04 -0.04 -0.04